Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus

NCT01826370 · clinicaltrials.gov ↗

TERMINATED

Status

678

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Linagliptin

Sponsor

Boehringer Ingelheim